Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about lead, mercury, arsenic, and other toxic elements in Ayurvedic products.

A careful reading is more useful than either blanket fear or blanket reassurance. Properly manufactured bhasma is not the same as accidental heavy-metal contamination in an herbal capsule, because its intended material, processing, particle size, and chemical form all matter. At the same time, laboratory testing has repeatedly found unsafe metals in some commercial Ayurvedic products, especially products bought from unverified sources. Safety depends on identity, classical processing, chemical speciation, batch testing, dose, duration, and medical supervision.

What Are Bhasma Preparations?

Bhasma means an ash-like calcined product. In Rasa Shastra pharmaceutics, a metal, mineral, shell, pearl, coral, or related material is processed through purification and incineration stages known broadly as shodhana and marana. The material may be triturated with herbal juices or decoctions, made into pellets, sealed in earthen containers, and repeatedly heated. The intended result is a fine, lusterless, stable preparation rather than crude metal powder.

Classical and pharmaceutic quality checks are used to judge whether incineration has reached the expected endpoint. Modern laboratories add elemental analysis and structural analysis to these traditional tests, because the same named bhasma can vary by raw material, heating method, number of calcination cycles, and manufacturer.

What Modern Analysis Adds

Modern testing separates several questions that are often mixed together: how much of an element is present, what chemical compound it is present as, what particle size and morphology it has, whether toxic impurities are present, and how much enters systemic circulation. ICP-MS, ICP-OES, ICP-AES, X-ray fluorescence, X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and related methods each answer different parts of that safety question.

Total metal content alone is not enough to judge a genuine metal-based bhasma, because a gold, iron, copper, zinc, tin, lead, or mercury preparation will naturally contain the intended element. For safety, total elemental analysis must be read together with chemical form, solubility, particle size, dose, duration, patient factors, and batch purity. For herbal-only products, however, lead, mercury, arsenic, and cadmium are contaminants unless clearly declared and justified by the formulation.

Swarna Bhasma: Gold Content, Particle Form, and Absorption

Swarna Bhasma is one of the most discussed bhasma preparations because gold is a noble metal and the prescribed doses are small. Published characterization work has reported gold as the major phase in prepared samples, but the percentage and particle dimensions vary across preparations and methods.

In one pharmaceutical standardization study, Swarna Bhasma prepared through a traditional method passed selected bhasma tests such as varitaratva, rekhapurnatva, and expected color. The finished product contained 52.33% gold by ICP-OES, with lead and cadmium below detection limits in that batch, while arsenic and mercury were detected. The same report also recorded particle sizes in the 1–10 µm range by spot magnification, showing that not every finished product can be described simply as a uniform nanoparticle preparation.

A human pilot bioavailability assessment administered Swarnabhasma in three regimens and measured blood gold using ICP-MS. Gold was detected only in trace amounts after a single dose. This supports cautious dosing and supervision rather than casual long-term self-use, because trace absorption does not remove the need for product identity and contaminant testing.

Tamra Bhasma: Copper Form Is Central to Safety

Tamra Bhasma requires special caution because copper in inappropriate form or excessive dose can cause gastrointestinal and systemic toxicity. The Ayurvedic safety logic is that copper must be purified, repeatedly processed, and converted into a stable bhasma that passes classical endpoint tests.

A quality-control study of Tamra Bhasma prepared from copper wire applied shodhana, marana, and amritikarana, then evaluated the final product using classical tests and modern tools. The final product passed tests such as rekhapurnatva and varitaratva. XRD showed prominent peaks of cupric sulfide, SEM showed particles below 2 µm, particle-size distribution gave a volumetric mean diameter of 28.70 µm, and ICP-AES measured 56.42% copper with 23.06% sulfur. Arsenic, lead, and mercury were present only in traces in that sample, while cadmium and selenium were not detected.

These details are important because they correct an oversimplified claim often made in discussions of Tamra Bhasma: a named bhasma cannot be assumed to be only one oxide form, nor can safety be inferred from name alone. The batch must be tested.

Lauha Bhasma and Yashada Bhasma: Iron and Zinc Preparations

Lauha Bhasma and Yashada Bhasma are often discussed as lower-concern metal bhasma when properly manufactured, because iron and zinc are essential elements. That does not mean they are risk-free. Excess iron can accumulate in susceptible patients, and zinc preparations can vary in chemical form and impurities.

Work on Lauha Bhasma preparation has described the importance of sequential purification and calcination in changing raw iron into a more processed iron-based material. Structural investigation of medicinal-grade Lauha Bhasma reported conversion of metallic iron into iron-oxide mineral phases, with magnetite microparticles appearing as agglomerates of nanoparticles. Yashada Bhasma analyses have reported zinc oxide or zinc sulfide phases depending on the processing method, with ICP-based elemental profiling used to assess trace elements and heavy metals.

The JAMA Internet-Product Survey: What It Really Means

The widely cited JAMA survey of Ayurvedic medicines sold via the internet remains highly relevant for public safety. It purchased 230 products, received and analyzed 193, and found detectable lead, mercury, or arsenic in 20.7% of products. Rasa Shastra products had a higher prevalence of detectable metals than non-Rasa Shastra products, and all metal-containing products exceeded at least one standard for acceptable daily intake of toxic metals.

The survey should be read as a serious product-quality warning. It tested commercial products bought online, not carefully supervised individualized prescribing from a qualified practitioner. It also measured metal concentrations rather than clinical pharmacokinetics or chemical speciation. Still, its practical message is unavoidable: consumers cannot assume an Ayurvedic label, an online listing, or a stated GMP claim guarantees safety.

Total Metal, Chemical Form, and Bioavailability

Total metal content answers only one part of the safety question. Iron oxide, elemental iron, soluble iron salts, and iron bound in hemoglobin all contain iron but behave differently in the body. The same principle applies to copper, zinc, mercury, lead, and arsenic: chemical form and solubility matter.

Mercury illustrates the point clearly. Cinnabar and mercuric sulfide are poorly absorbed from the gastrointestinal tract compared with methylmercury and more soluble mercury salts. This distinction is chemically meaningful, but it is not a license for self-medication with mercury-containing preparations. Poor absorption does not mean zero absorption, and cumulative exposure, impurities, overheating, wrong processing, wrong dose, and vulnerable patients can still create risk.

Which Bhasma Carry Lower or Higher Concern?

A practical safety ranking should not claim that any bhasma is automatically safe. It should separate lower-concern mineral preparations from preparations that contain toxic metals or require especially narrow dosing discipline.

Lower Concern When Properly Manufactured

Some preparations are based mainly on calcium carbonate, silicate minerals, iron, or zinc. Their risk is usually driven by product purity, inappropriate indication, wrong dose, prolonged use, and patient susceptibility rather than by the inherent toxicity of lead or mercury.

• Shankha Bhasma: A conch-shell preparation, mainly calcium-rich, traditionally used for acid-peptic and digestive indications.
• Praval and Mukta preparations: Coral and pearl preparations are calcium-carbonate based but still require authenticity and contaminant checks.
• Abhraka Bhasma: A mica-based silicate preparation requiring careful processing and batch standardization.
• Lauha Bhasma: Iron-based; avoid unnecessary use in people with high ferritin, iron overload disorders, active infection concerns, or liver disease unless supervised.
• Yashada Bhasma: Zinc-based; avoid combining with other zinc supplements unless clinically indicated.

Moderate Concern Requiring Active Monitoring

These preparations can be clinically important in traditional practice, but the margin for error is smaller. Their use should be individualized, time-limited, and supported by batch-level testing.

• Tamra Bhasma: Copper-based; unsuitable for casual use, prolonged unsupervised courses, or patients with copper metabolism disorders.
• Vanga Bhasma: Tin-based; requires reliable manufacturing and practitioner supervision.
• Rajata Bhasma: Silver-based; chronic unnecessary exposure should be avoided.

High Concern and Specialist Use Only

Preparations containing lead, mercury, arsenic compounds, or closely related toxic mineral inputs require the highest safety threshold. They should never be treated as wellness supplements.

• Naga Bhasma: Lead-based; lead exposure is a genuine toxicological concern even when processed.
• Parada, Rasa Sindura, Makaradhwaja, and related mercury preparations: Require expert Rasa Shastra knowledge, legal compliance, contaminant testing, clear indication, limited duration, and monitoring.
• Formulations containing arsenic minerals: Require exceptional caution and should not be used without specialist oversight.

Quality Control Recommendations for Practitioners and Patients

The safest approach combines classical Rasa Shastra standards with modern laboratory quality control. Neither system should be used as a substitute for the other.

1. Use qualified supervision only: Bhasma preparations should be prescribed by a qualified Ayurvedic practitioner trained in Rasa Shastra, not self-selected from online listings.
2. Demand batch-level testing: A certificate of analysis should identify the batch and include elemental testing for lead, mercury, arsenic, cadmium, and relevant intended metals.
3. Prefer transparent manufacturers: The label should show batch number, manufacturing license details, ingredients, expiry, dose guidance, and safety warnings.
4. Verify identity and classical quality: Classical tests such as nishchandratva, rekhapurnatva, and varitaratva remain useful screening tools when performed by trained practitioners.
5. Avoid casual online purchase: Products sold without practitioner oversight, batch documentation, or transparent testing carry avoidable risk.
6. Use the lowest appropriate dose for the shortest appropriate duration: This principle is especially important for copper-, lead-, mercury-, arsenic-, and silver-containing preparations.
7. Use modern monitoring when risk is higher: Depending on the preparation, consider baseline and follow-up blood lead level, mercury level, liver function, kidney function, complete blood count, ferritin, copper status, or zinc status.
8. Disclose all medicines: Patients should tell both Ayurvedic and conventional healthcare providers about bhasma use, especially before surgery, pregnancy planning, or treatment for liver, kidney, neurological, gastrointestinal, or hematologic disease.

The Nanoparticle Dimension

Many bhasma discussions now use the word nanoparticle, but this needs precision. Some preparations contain nanoscale crystallites, some contain agglomerates of nanoparticles, and some measured batches show micrometre-scale particles. Particle size depends on raw material, grinding, calcination cycles, analytical method, and whether the measurement captures primary particles or agglomerates.

Nanoscale features may influence dissolution, surface area, tissue interaction, and dose behavior. They also add modern safety questions, because nanoscale materials can behave differently from bulk materials. For bhasma safety, particle-size claims should come from batch-specific SEM, TEM, XRD, DLS, or comparable analysis, not from the word bhasma alone.

A Balanced Safety Position

The most defensible position is neither to reject all bhasma as poison nor to accept all bhasma as safe. Properly prepared and properly prescribed bhasma is a distinct pharmaceutic category within Ayurveda. Poorly prepared, adulterated, mislabeled, or casually purchased products can cause real harm.

• Classical processing matters because incomplete incineration can leave unsuitable material.
• Modern batch testing matters because classical tests cannot quantify lead, mercury, arsenic, cadmium, or unintended contaminants.
• Chemical form matters because total elemental content does not equal absorbed toxic dose.
• Patient selection matters because children, pregnant or breastfeeding patients, and people with liver, kidney, neurological, or metabolic disorders may have much higher risk.
• Lead-, mercury-, and arsenic-containing preparations deserve the highest threshold of caution and should never be used as casual wellness supplements.

For a broader discussion of how carrier substances influence Ayurvedic administration, see The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Bhasma preparations should be used only under the supervision of a qualified Ayurvedic practitioner and, when appropriate, in coordination with a conventional healthcare provider. Do not self-medicate with mineral, metal, mercury, lead, arsenic, or herbo-mineral preparations. Seek medical care promptly if you develop abdominal pain, nausea, vomiting, constipation, metallic taste, fatigue, high blood pressure, tremor, neuropathy, confusion, anemia, kidney problems, or other symptoms suggestive of heavy-metal exposure. Children, pregnant or breastfeeding people, and patients with liver, kidney, neurological, or serious chronic illness should avoid bhasma unless a qualified specialist determines that use is appropriate and monitored.

References

1. Pdfs (pdfs.semanticscholar.org)
2. Pdfs (pdfs.semanticscholar.org)
3. Aamjournal (aamjournal.in)
4. Assessment of bioavailability of gold bhasma in human participants – A pilot study (2018), PubMed Central
5. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed
6. Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? (2008), PubMed Central
7. FDA
8. Ayush (ayush.delhi.gov.in)
9. Pib (pib.gov.in)
10. Scientific validation of the different purification steps involved in the preparation of an Indian Ayurvedic medicine, Lauha bhasma (2012), PubMed
11. Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central
12. Mail (mail.greenpharmacy.info)
13. Ijpsonline (ijpsonline.com)